In this video, Dr Didier Tchetche (Clinique Pasteur, Toulouse, FR) and Dr Gilbert Tang (Mount Sinai Hospital, New York, US) discuss the EVOLUT™ PRO+ TAVI platform that was recently CE marked.

Learn more about how the new Evolut™ PRO+ TAVI system translates to clinical benefits for SSAS patients and see how the importance of a lower delivering system does not compromise the valve performance. The faculty focus on the lower risk of vascular complications and a large valve's benefits with a pericardial wrap. Lastly, Dr Gilbert Tang outlines his experience with this new TAVI platform and gives an overview about the new clinical data available.
 

AGENDA

Introduction 
Introduction and Objectives 

Presentations and Discussions: 

The Corevalve Evolut™ platform evolution and key clinical data      
What is PRO+ and what is new? – New platform features
The lower DS profile and the lower risk of vascular complications
The new 34mm PRO+ valve - The importance of the pericardial wrap
The US experience with PRO+ platform

The cusp overlap technique with PRO+ (Optimize PRO study)

Conclusions